Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gastric Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    June 2019
  1. QIU MZ, He CY, Lu SX, Guan WL, et al
    Prospective Observation: Clinical Utility of Plasma Epstein-Barr-Virus DNA Load in EBV-associated Gastric Carcinoma Patients.
    Int J Cancer. 2019 Jun 4. doi: 10.1002/ijc.32490.
    PubMed     Text format     Abstract available


    May 2019
  2. BOBROVNITCHAIA I, Valieris R, Drummond Couto Duarte R, Lima JP, et al
    APOBEC-mediated DNA alterations: a possible new mechanism of carcinogenesis in EBV-positive gastric cancer.
    Int J Cancer. 2019 May 15. doi: 10.1002/ijc.32411.
    PubMed     Text format     Abstract available


  3. SANIKINI H, Muller DC, Sophiea M, Rinaldi S, et al
    Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
    Int J Cancer. 2019 May 3. doi: 10.1002/ijc.32386.
    PubMed     Text format     Abstract available


    April 2019
  4. CHEN Z, Liu Z, Zhang M, Huang W, et al
    EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2-mediated MAPK pathway activation in gastric cancer cells and avatar mice.
    Int J Cancer. 2019 Apr 7. doi: 10.1002/ijc.32313.
    PubMed     Text format     Abstract available


  5. HAAG GM, Czink E, Ahadova A, Schmidt T, et al
    Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
    Int J Cancer. 2019;144:1697-1703.
    PubMed     Text format     Abstract available


    March 2019
  6. ROTA M, Alicandro G, Pelucchi C, Bonzi R, et al
    Education and gastric cancer risk - An individual participant data meta-analysis in the StoP project consortium.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32298.
    PubMed     Text format     Abstract available


  7. DIZDAR L, Werner TA, Drusenheimer JC, Mohlendick B, et al
    BRAF(V600E) mutation: A promising target in colorectal neuroendocrine carcinoma.
    Int J Cancer. 2019;144:1379-1390.
    PubMed     Text format     Abstract available


    February 2019
  8. CHO J, Ahn S, Son DS, Kim NK, et al
    Bridging Genomics and Phenomics of Gastric Carcinoma.
    Int J Cancer. 2019 Feb 23. doi: 10.1002/ijc.32228.
    PubMed     Text format     Abstract available


    January 2019
  9. KIM YB, Ahn JM, Bae WJ, Sung CO, et al
    Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32140.
    PubMed     Text format     Abstract available


  10. TAHARA S, Tahara T, Horiguchi N, Kato T, et al
    DNA methylation accumulation in gastric mucosa adjacent to cancer after Helicobacter pylori eradication.
    Int J Cancer. 2019;144:80-88.
    PubMed     Text format     Abstract available


    December 2018
  11. LIU YD, Yu L, Ying L, Balic J, et al
    Toll-like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2.
    Int J Cancer. 2018 Dec 11. doi: 10.1002/ijc.32060.
    PubMed     Text format     Abstract available


  12. BERTUCCIO P, Alicandro G, Rota M, Pelucchi C, et al
    Citrus fruit intake and gastric cancer: the Stomach cancer Pooling (StoP) project consortium.
    Int J Cancer. 2018 Dec 6. doi: 10.1002/ijc.32046.
    PubMed     Text format     Abstract available


  13. WANG S, Freedman ND, Loftfield E, Hua X, et al
    Alcohol consumption and risk of gastric cardia adenocarcinoma and gastric noncardia adenocarcinoma: A 16-year prospective analysis from the NIH-AARP diet and health cohort.
    Int J Cancer. 2018;143:2749-2757.
    PubMed     Text format     Abstract available


    November 2018
  14. ZHANG H, Zhu L, Bai M, Liu Y, et al
    Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31977.
    PubMed     Text format     Abstract available


    October 2018
  15. CHEN J, Guo H, Jiang H, Namusamba M, et al
    A BAP31 intrabody induces gastric cancer cell death by inhibiting p27(kip1) proteasome degradation.
    Int J Cancer. 2018 Oct 19. doi: 10.1002/ijc.31930.
    PubMed     Text format     Abstract available


  16. KATZ LH, Levi Z, Twig G, Kark JD, et al
    Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescents.
    Int J Cancer. 2018;143:1876-1883.
    PubMed     Text format     Abstract available


    September 2018
  17. MINAMI Y, Kanemura S, Oikawa T, Suzuki S, et al
    Associations of cigarette smoking and alcohol drinking with stomach cancer survival: A prospective patient cohort study in Japan.
    Int J Cancer. 2018;143:1072-1085.
    PubMed     Text format     Abstract available


    August 2018
  18. COMPANIONI O, Bonet C, Garcia N, Lazaro MJR, et al
    Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14.
    Int J Cancer. 2018 Aug 31. doi: 10.1002/ijc.31839.
    PubMed     Text format     Abstract available


  19. GYAWALI B, Kesselheim AS, D'Andrea E
    Does Helicobacter pylori eradication therapy to prevent gastric cancer increase all-cause mortality?
    Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31772.
    PubMed     Text format     Abstract available


  20. MC MENAMIN UC, Kunzmann AT, Cook MB, Johnston BT, et al
    Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.
    Int J Cancer. 2018;143:831-841.
    PubMed     Text format     Abstract available


  21. WOO HD, Fernandez-Jimenez N, Ghantous A, Degli Esposti D, et al
    Genome-wide profiling of normal gastric mucosa identifies Helicobacter pylori- and cancer-associated DNA methylome changes.
    Int J Cancer. 2018;143:597-609.
    PubMed     Text format     Abstract available


    July 2018
  22. CHENG L, Qiu L, Zhang R, Qian D, et al
    Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31656.
    PubMed     Text format     Abstract available


  23. TAN J, Fu L, Chen H, Guan J, et al
    Association study of genetic variation in the autophagy lysosome pathway genes and risk of eight kinds of cancers.
    Int J Cancer. 2018;143:80-87.
    PubMed     Text format     Abstract available


    June 2018
  24. NDEGWA N, Ploner A, Liu Z, Roosaar A, et al
    Association between poor oral health and gastric cancer: A prospective cohort study.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31614.
    PubMed     Text format     Abstract available


    May 2018
  25. MIZUGUCHI A, Takai A, Shimizu T, Matsumoto T, et al
    Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
    Int J Cancer. 2018 May 1. doi: 10.1002/ijc.31578.
    PubMed     Text format     Abstract available


    April 2018
  26. SHAO L, Li P, Ye J, Chen J, et al
    Risk of gastric cancer among patients with gastric intestinal metaplasia.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31571.
    PubMed     Text format     Abstract available


    March 2018
  27. KIYOZUMI Y, Iwatsuki M, Kurashige J, Ogata Y, et al
    PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
    Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31410.
    PubMed     Text format     Abstract available


  28. KIM H, Keum N, Giovannucci EL, Fuchs CS, et al
    Garlic intake and gastric cancer risk: results from two large prospective US cohort studies.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31396.
    PubMed     Text format     Abstract available


    February 2018
  29. TER VEER E, Creemers A, de Waal L, van Oijen MGH, et al
    Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31325.
    PubMed     Text format     Abstract available


  30. KIM HJ, Kang SK, Kwon WS, Kim TS, et al
    Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31304.
    PubMed     Text format     Abstract available


  31. HILL DG, Yu L, Gao H, Balic JJ, et al
    Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
    Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31298.
    PubMed     Text format     Abstract available


    January 2018
  32. ISHIKAWA T, Okayama T, Sakamoto N, Ideno M, et al
    Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31285.
    PubMed     Text format     Abstract available


    December 2017
  33. WANG W, Li Z, Wang J, Du M, et al
    A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31197.
    PubMed     Text format     Abstract available


    October 2017
  34. RHYU MG, Oh JH, Hong SJ
    Species-specific role of gene-adjacent retroelements in human and mouse gastric carcinogenesis.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31120.
    PubMed     Text format     Abstract available


  35. LUO G, Zhang Y, Guo P, Wang L, et al
    Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis.
    Int J Cancer. 2017;141:1333-1344.
    PubMed     Text format     Abstract available


    July 2017
  36. LIU X, Zhang X, Zhang Z, Chang J, et al
    Plasma MicroRNA-based Signatures to Predict 3-year Postoperative Recurrence Risk for Stage II and III Gastric Cancer.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30895.
    PubMed     Text format     Abstract available


  37. ROTA M, Pelucchi C, Bertuccio P, Matsuo K, et al
    Alcohol consumption and gastric cancer risk - A pooled analysis within the StoP Project Consortium.
    Int J Cancer. 2017 Jul 18. doi: 10.1002/ijc.30891.
    PubMed     Text format     Abstract available


  38. TAKEGAWA N, Nonagase Y, Yonesaka K, Sakai K, et al
    DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30870.
    PubMed     Text format     Abstract available


  39. YU G, Hu N, Wang L, Wang C, et al
    Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China.
    Int J Cancer. 2017;141:45-51.
    PubMed     Text format     Abstract available


    June 2017
  40. KORSAK B, Almeida GM, Rocha S, Pereira C, et al
    Porphyrin Modified Trastuzumab Improves Efficacy of HER2 Targeted Photodynamic Therapy of Gastric Cancer.
    Int J Cancer. 2017 Jun 22. doi: 10.1002/ijc.30844.
    PubMed     Text format     Abstract available


    May 2017
  41. MIRANTI EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, et al
    Low Vitamin B12 Increases Risk of Gastric Cancer: A Prospective Study of One-Carbon Metabolism Nutrients and Risk of Upper Gastrointestinal Tract Cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30809.
    PubMed     Text format     Abstract available


  42. WANG X, Zhou Q, Yu Z, Wu X, et al
    Cancer-associated Fibroblast-derived Lumican Promotes Gastric Cancer Progression via the integrin beta1-FAK signaling pathway.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30801.
    PubMed     Text format     Abstract available


  43. JAKSZYN P, Fonseca-Nunes A, Lujan-Barroso L, Aranda N, et al
    Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study.
    Int J Cancer. 2017 May 22. doi: 10.1002/ijc.30797.
    PubMed     Text format     Abstract available


    April 2017
  44. BUSBY J, Murchie P, Murray L, Iversen L, et al
    The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Int J Cancer. 2017;140:1828-1835.
    PubMed     Text format     Abstract available


    February 2017
  45. RONCHETTI L, Melucci E, De Nicola F, Goeman F, et al
    DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30668.
    PubMed     Text format     Abstract available


  46. MUHAMMAD JS, Nanjo S, Ando T, Yamashita S, et al
    Autophagy Impairment by Helicobacter pylori-induced Methylation Silencing of MAP1LC3Av1 Promotes Gastric Carcinogenesis.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30657.
    PubMed     Text format     Abstract available


    December 2016
  47. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available


  48. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Text format     Abstract available


    October 2016
  49. WANG T, Cai H, Sasazuki S, Tsugane S, et al
    Fruit and Vegetable Consumption, Helicobacter pylori Antibodies, and Gastric Cancer Risk: A Pooled Analysis of Prospective Studies in China, Japan and Korea.
    Int J Cancer. 2016 Oct 19. doi: 10.1002/ijc.30477.
    PubMed     Text format     Abstract available


  50. NAGASE H, Takeoka T, Urakawa S, Morimoto-Okazawa A, et al
    ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.
    Int J Cancer. 2016 Oct 18. doi: 10.1002/ijc.30475.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: